MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinsonism secondary to mercury poisoning in a Colombian population

J. Vargas (Bogotá, Colombia)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1145

Keywords: Parkinsonism

Category: Parkinsonism, Others

Objective: To describe the clinical and paraclinical characteristics of patients over 18 years of age who consulted the Neurology service of the University Hospital with diagnosis of mercury poisoning and parkinsonism in the period of 2015-2017.

Background: Mercury is a heavy metal and its compounds are recognized as potentially hazardous materials. Industrial growth, and especially fluorescent lamps, has increased the exposure and the risk of mercury poisoning. Through environmental studies and case-control studies, demonstrated that mercury is related to the presence of parkinsonism.

Method: Descriptive observational study of patients diagnosed with mercury poisoning and secondary parkinsonism, in a Neurology clinic of the University Hospital between 2015-2016. Sociodemographic, clinical and laboratory, collected in each patient.

Results: A total of 7 individuals are reported in whom an intoxication is evidenced by mercury secondary to occupational exposure and that after chelation and management of acute symptoms present parkinsonism. Of the individuals studied, 100% were male and belonged to a company that produces fluorescent lamps; the age range was 38-50 years. In these patients, the range of mercury levels at admission was 93-761 μg / l with controls after chelation in the office neurology lower than 20 μg / l in blood; In addition, intoxication by other heavy metals was ruled out in all patients. 100% of the patients consulted for symptoms due to tremor at rest and bradykinesia, in addition to stiffness, with a positive levodopa test and a score on the MDS-UPDRS-III scale of 5-18.

Conclusion: The results of this study suggest that there is a possible association of occupational exposure to mercury (with acute intoxication) and subsequent parkinsonism, however, larger and more methodologically robust studies are required to determine this association. This study is the first in the country to report an empirical association of mercury poisoning and parkinsonism.

References: Agency for Toxic Substances and Disease Registry (ATSDR). Evaluating Mercury Exposure: Information for Health Care Providers. 2011. pp. 1–2. 2. Gasca-Alvarez A. Exposición ambiental a mercurio en minas de oro: medición del impacto en la salud en Guainia, Colombia. Rev. Salud Pública (Bogotá); 2000. 3. Osorio García SD, Hernández Flores LJ, Sarmiento R, González Álvarez Y, Perez Castiblanco DM, Barbosa Devia MZ, et al. Prevalencia de mercurio y plomo en población general de Bogotá 2012/2013. Revista de Salud Pública. 2015 Mar 6;16(4):621–8.

To cite this abstract in AMA style:

J. Vargas. Parkinsonism secondary to mercury poisoning in a Colombian population [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/parkinsonism-secondary-to-mercury-poisoning-in-a-colombian-population/. Accessed July 9, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinsonism-secondary-to-mercury-poisoning-in-a-colombian-population/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley